Please login to the form below

simeprevir

This page shows the latest simeprevir news and features for those working in and with pharma, biotech and healthcare.

Remicade safe from biosimilar competition this year, says J&J

On the downside, hepatitis C therapy Olysio/Sovriad (simeprevir) continued its decline in the face of strong competition in the marketplace from Gilead and AbbVie, falling 86% to just $32m in

Latest news

2015's 'premium' prices dissuaded J&J from acquisitions, says Gorsky

to $8.1bn despite heavy competition to hepatitis C therapies Olysio (simeprevir) and Incivo (telaprevir) from Gilead and AbbVie.
J&J's share buyback 'doesn't prevent acquisitions'

disease and arthritis drug Remicade (infliximab) and Olysio (simeprevir) for hepatitis C virus offset by growth in newer products.
J&J starts to feel biosimilar competition bite

toll on J&J's Olysio (simeprevir) and Incivek (telaprevir) products.
J&J signs $1bn deal with Achillion for hepatitis C therapies

J&J already has one new-generation oral HCV therapy on the market, its NS3/4A protease inhibitor Olysio (simeprevir), but could do with additional drugs in its portfolio in order
Harvoni sales rocket in first quarter

simeprevir), while Merck &Co also has a new treatment in the works.

More from news
Approximately 9 fully matching, plus 32 partially matching documents found.

Latest Intelligence

Taking a strategic approach

Meanwhile, for Olysio (simeprevir) - one of several new oral drugs that mark a major step forward in hepatitis C treatment - it was an innovative 'pay-if-you-clear' scheme that persuaded

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Medivir names new CEO

simeprevir). “Medivir is an attractive company in an exciting phase of its development following the successful market introduction of simeprevir,” he said.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Warehousing of HCV patients reaches new high

Gilead’s interferon-free product sofosbuvir and Johnson &Johnson’s simeprevir appear to lead the field – receiving the highest levels of spontaneous and prompted awareness. ... However, Abbvie’s products ABT 267, ABT 333 and ABT 450 remain

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Medical Writer: Competitive salary and benefits

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

PR Associate Director – Consumer Health & Beauty: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Senior Medical Writer: Salary TBC

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

NEW FREELANCE OPPORTUNITIES!!! LONDON and HOME WORKING!: EXCELLENT DAY RATES AVAILABLE

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Director – Healthcare PR: Salary TBC

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Director, Medical Education: Salary TBC

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Subscribe to our email news alerts

PMHub

Add my company

Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...